Lifestyle changes for cognition and dementia: better than a new drug?

shutterstock_2378100

Should all molecular research institutes looking at neurodegenerative diseases be replaced by parks, playgrounds and cycle paths? Mark Horowitz highlights a recent systematic review of modifiable risk factors associated with cognition and dementia, which suggests that from a public health perspective, there may be some sense in this idea.

[read the full story...]

Risk factors for dementia: separating the facts from the myths

shutterstock_223825078

We are grateful to Josephine Neale who has read the 104 page World Alzheimer Report 2014 and summarised it for us in this very readable blog. The report is a comprehensive analysis of the risk factors for dementia, which focuses on a range of protective and modifiable factors.

[read the full story...]

Cognitive and exercise interventions for older adults with and without cognitive impairment

Image: Diabetes Care (CC BY-NC 2.0)

Jake Crawshaw reports on a recent systematic review of cognitive and exercise interventions for older people with and without cognitive impairment.

[read the full story...]

Alternatives to medication for agitation in dementia

shutterstock_183376727

Andrés Fonseca summarises the findings of a recent systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in dementia.

[read the full story...]

What should we prescribe for neuropsychiatric symptoms in Alzheimer’s disease?

shutterstock_70709260

Psychiatrist Andrés Fonseca considers how his clinical practice should change, after reading a systematic review and meta-analysis of drug treatment for neuropsychiatric symptoms in Alzheimer’s disease

[read the full story...]

Which (if any) drugs should we use for agitated or aggressive behaviour in dementia?

shutterstock_135340304

This is a dilemma I frequently face when I am called out to see someone with dementia on the ward or living in a nursing home. On the one hand I am thinking that anything I use can potentially have serious side-effects and will probably lead to increased health risks and increased mortality. On the [read the full story...]

Cochrane review finds no good quality evidence for common medicines used to treat sleep problems in Alzheimer’s Disease

shutterstock_122429272

People with dementia caused by Alzheimer’s Disease (ADD) (which is estimated to be around three quarters of people with dementia) often suffer from sleep disturbances.  These symptoms cause distress to the person with dementia and to their carers, increase the likelihood of admission to a care home, and are also very difficult for care home [read the full story...]

Dealing with a diagnosis of dementia: putting a systematic review into context

shutterstock_160164149

Last July I wrote a blog (Helping patients and carers deal with a diagnosis of dementia: one size doesn’t fit all) about a systematic review of qualitative evidence (Bunn, 2012) relating to patients and carers experiences of reaching and adapting to a diagnosis of dementia.  That blog was heavily influenced by personal experience of my [read the full story...]

New Cochrane review says that vitamin E should not be used to treat dementia

shutterstock_109104293

It was relatively recently that every Tom, Dick and Harry in the scientific community was popping vitamin E supplements in the hope that this antioxidant would help protect them from the damaging effects of free radicals. Us elves get our vitamin E from the vegetables, fruits and whole grains that make up our naturally healthy diet. Many single [read the full story...]